INDV
INDV
US45579U1097
Indivior Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.23B EUR
4.84B EUR
3.72B EUR
4.49B EUR
Enterprise Value
4.47B EUR
5.13B EUR
4.05B EUR
4.64B EUR
Valuation Multiples
Trailing P/E
12.84x
13.64x
14.81x
27.69x
Forward P/E
7.34x
--
--
--
Price to Sales
3.18x
3.63x
2.88x
4.61x
Price to Book
--
--
--
--
EV/Revenue
3.36x
3.85x
3.14x
4.77x
EV/EBITDA
7.76x
11.22x
10.84x
20.18x
Price to FCF (P/FCF)
48.89x
--
--
--
EV/FCF
51.68x
--
--
--
FCF Yield
2.05%
-2.29%
-5.19%
-3.66%
ende